Author： Willemsen Anna E. C. A. B. van Herpen Carla M. L.
Publisher： Informa Healthcare
ISSN： 0284-186X
Source： Acta Oncologica, Vol.52, Iss.6, 2013-08, pp. : 1234-1234
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Access to resources
Recommend
By Iacovelli Roberto Palazzo Antonella Mezi Silvia Morano Federica Naso Giuseppe Cortesi Enrico
Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. :
Role of mTOR inhibitor in cholangiocarcinoma cell progression
Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. :
Mechanisms of mTOR inhibitor resistance in cancer therapy
Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. :
By Ladoire Sylvain Beynat Caroline Diaz Pierre Coudert Bruno Favier Laure Ghiringhelli François
Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. :